Correlation Between Ardelyx and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Kiromic Biopharma, you can compare the effects of market volatilities on Ardelyx and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Kiromic Biopharma.
Diversification Opportunities for Ardelyx and Kiromic Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ardelyx and Kiromic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Ardelyx i.e., Ardelyx and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Ardelyx and Kiromic Biopharma
If you would invest 534.00 in Ardelyx on November 9, 2024 and sell it today you would earn a total of 33.00 from holding Ardelyx or generate 6.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Ardelyx vs. Kiromic Biopharma
Performance |
| Timeline |
| Ardelyx |
| Kiromic Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Ardelyx and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ardelyx and Kiromic Biopharma
The main advantage of trading using opposite Ardelyx and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |